BIOMAT Database Logo BIOMAT Database Logo

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. 1991

T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Medical Department, Ross Laboratories Division of Abbott Laboratories, Columbus, Ohio 43215.

Acute Respiratory Distress Syndrome (ARDS) is characterized by lung injury and damage to the alveolar type II cells. This study sought to determine if endogenous surfactant is altered in ARDS. Bronchoalveolar lavage was performed in patients at-risk to develop ARDS (AR, n = 20), with ARDS (A, n = 66) and in normal subjects (N, n = 29). The crude surfactant pellet was analyzed for total phospholipids (PL), individual phospholipids, SP-A, SP-B, and minimum surface tension (STmin). PL was decreased in both AR and A (3.48 +/- 0.61 and 2.47 +/- 0.40 mumol/ml, respectively) compared to N (7.99 +/- 0.60 mumol/ml). Phosphatidylcholine was decreased in A (62.64 +/- 2.20% PL) compared to N (76.27 +/- 2.05% PL). Phosphatidylglycerol was 11.58 +/- 1.21% PL in N and was decreased to 6.48 +/- 1.43% PL in A. SP-A was 123.64 +/- 20.66 micrograms/ml in N and was decreased to 49.28 +/- 21.68 micrograms/ml in AR and to 29.88 +/- 8.49 micrograms/ml in A. SP-B was 1.28 +/- 0.33 micrograms/ml in N and was decreased to 0.57 +/- 0.24 micrograms/ml in A. STmin was increased in AR (15.1 +/- 2.53 dyn/cm) and A (29.04 +/- 2.05 dyn/cm) compared to N (7.44 +/- 1.61 dyn/cm). These data demonstrate that the chemical composition and functional activity of surfactant is altered in ARDS. Several of these alterations also occur in AR, suggesting that these abnormalities occur early in the disease process.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant for acute respiratory distress syndrome.
January 1997, Advances in internal medicine,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant therapy in acute respiratory distress syndrome.
September 1998, Biology of the neonate,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Respiratory mechanics and surfactant in the acute respiratory distress syndrome.
November 1998, Clinical and experimental pharmacology & physiology,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant treatment for acute respiratory distress syndrome.
March 1999, Archives of disease in childhood,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant medication for acute respiratory distress syndrome.
August 1997, Thorax,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
February 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant alteration and replacement in acute respiratory distress syndrome.
January 2001, Respiratory research,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Composition and function of pulmonary surfactant in adult respiratory distress syndrome.
March 1989, The European respiratory journal. Supplement,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
[Surfactant and respiratory distress syndrome].
July 1978, Praxis und Klinik der Pneumologie,
T J Gregory, and W J Longmore, and M A Moxley, and J A Whitsett, and C R Reed, and A A Fowler, and L D Hudson, and R J Maunder, and C Crim, and T M Hyers
Surfactant and respiratory distress syndrome.
January 1996, The Turkish journal of pediatrics,
Copied contents to your clipboard!